APA

Xie Y., Liu Z., Zhang G., Mo X., Ding X., Xia L. & Hu S. (20170306). A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. : Research in microbiology.

Chicago

Xie Yali, Liu Zhengqiang, Zhang Guoyong, Mo Xiangtao, Ding Xuezhi, Xia Liqiu and Hu Shengbiao. 20170306. A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. : Research in microbiology.

Harvard

Xie Y., Liu Z., Zhang G., Mo X., Ding X., Xia L. and Hu S. (20170306). A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. : Research in microbiology.

MLA

Xie Yali, Liu Zhengqiang, Zhang Guoyong, Mo Xiangtao, Ding Xuezhi, Xia Liqiu and Hu Shengbiao. A rifampicin-resistant (rpoB) mutation in Pseudomonas protegens Pf-5 strain leads to improved antifungal activity and elevated production of secondary metabolites. : Research in microbiology. 20170306.